Abstract

Neuropeptide oxytocin (OT) is involved in the regulation of social and non-social behaviour. The central nucleus of amygdala (CeA), part of the limbic system, plays an important role in learning, memory, anxiety and reinforcing mechanisms. CeA has been shown to be rich in OT receptors in rodents. Our previous findings indicated that OT in the rat CeA has a dose dependent rewarding and anxiolytic effect. The aim of our present study was to examine in the CeA the possible interaction of OT and D2 dopamine (DA) receptor antagonist Sulpiride on reinforcement in place preference test and on anxiety in elevated plus maze test.Wistar rats were microinjected bilaterally with 10 ng OT. In different group of animals 4 μg D2 DA receptor antagonist was applied. Other animals received D2 DA receptor antagonist 15 min before 10 ng OT treatment or vehicle solution into the CeA. Rats receiving 10 ng OT spent significantly longer time in the treatment quadrant during the test session in conditioned place preference test. Prior treatment with D2 DA receptor antagonist blocked the rewarding effects of OT. Antagonist in itself did not influence the time rats spent in the treatment quadrant. In elevated plus maze test, rats receiving 10 ng OT spent significantly longer time on the open arms. Prior treatment with D2 DA receptor antagonist blocked the effects of OT.Our results show that DA system plays a role in positive reinforcing and anxiolytic effects of OT because D2 DA receptor antagonist can block these actions.

Highlights

  • Nonapeptide oxytocin (OT) is widely distributed in the central nervous system where it acts as a neurotransmitter and neuromodulator

  • Our results show that DA system plays a role in positive reinforcing and anxiolytic effects of OT because D2 DA receptor antagonist can block these actions

  • D2 DA receptor antagonist + OT treatment Our previous data showed that OT has positive reinforcing properties when microinjected into the rat central nucleus of amygdala (CeA) (Laszlo et al, 2016)

Read more

Summary

Introduction

Nonapeptide oxytocin (OT) is widely distributed in the central nervous system where it acts as a neurotransmitter and neuromodulator. OT is mainly produced by the paraventricular, supraoptic and accessory nuclei of the hypothalamus and it is released into numerous brain regions including the central nucleus of amygdala (CeA) (Voorn and Buijs, 1983; Knobloch et al, 2012; Grinevich et al, 2016). Amygdala (AMY) plays an important role in the regulation of fear, anxiety, reinforcement, sexual behaviour and motivation. The CeA has been shown to be relatively rich in oxytocin receptors (OTR) and receives oxytocinergic fibers from hypothalamus (Voorn and Buijs, 1983; Condeslara et al, 1994; Knobloch et al, 2012). OT has been demonstrated to attenuate AMY responses in aversive situations (Sobota et al, 2015) and modulates AMY reactivity to masked fearful eyes (Kanat et al, 2015)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call